The upcoming TechCrunch Founder Summit 2026 offers hands-on programming across its Build and Impact stages, interactive roundtables, and an Expo Hall on November 4. Using the Braindate platform, attendees can organize tailored conversations on pressing topics like hiring hurdles and product-market fit. Notable speakers including Bessemer Venture Partners' Kent Bennett and Toast co-founder Steve Fredette will share practical guidance on scaling operations. Attendees can currently secure registration with a discount of up to $100 alongside a complimentary second ticket.
Key points
Braindate enables attendees to pre-schedule targeted one-on-one and small-group discussio…: Braindate enables attendees to pre-schedule targeted one-on-one and small-group discussions on topics like fundraising and hiring.
The summit agenda prioritizes practical business execution, featuring interactive roundta…: The summit agenda prioritizes practical business execution, featuring interactive roundtables, live pitch sessions, and stage presentations.
Every pass holder gains access to the event facilities as well as comprehensive post-even…: Every pass holder gains access to the event facilities as well as comprehensive post-event session materials.
Sources checked by our analysis pipeline: 1
The best connection you make at an event is not always the person standing next to you in line for coffee. Sometimes it is the founder who has already solved the problem keeping you up at night. The investor who can challenge the way you are thinking about your next round. Or the operator who has learned firsthand what happens when a company scales too quickly.
At TechCrunch Founder Summit 2026, happening November 4 at SoWa Power Station in Boston, networking powered by Braindate is designed to make those conversations easier to find, whether they are in 1:1 or small-group on-site meetings.
The only way to make these game-changing connections is at Founder Summit. Grab your pass, plus get a second pass for free.
Networking with a purpose
The Founder Summit Networking Lounge gives attendees the opportunity to schedule one-on-one or small-group Braindates throughout the day.
Instead of hoping to run into the right person, Braindate lets you connect around the topics you actually want to discuss. Bring a challenge. Share something you have learned. Ask for perspective. Offer your…
Biopharmaceutical firm Vir Biotechnology has named David Liu as its new chief medical officer to oversee clinical leadership. Liu steps into the position after previously holding the identical executive role at Nuvation Bio. The appointment was highlighted within an ongoing industry tracking series that monitors key executive transitions.
Margin compression during the quarter stemmed from heavy digital commerce investments, absorbed cost inflation, and rising finance expenses tied to increased borrowings. A calendar shift pushing key festive events into the subsequent period, combined with higher depreciation from ongoing physical expansion, further weighed on the bottom line. Despite these near-term headwinds, operational volume remained steady as footfalls and engagement translated into positive top-line growth.
The top executive clarified that the energy giant is not evaluating a split of its operations, moving swiftly to shut down recent market rumors. By firmly addressing the matter, leadership aims to reassure stakeholders and maintain focus on the firm's integrated corporate structure. The direct dismissal leaves no ambiguity regarding the firm's immediate organizational strategy.